445 filings
Page 16 of 23
6-K
CLLS
Cellectis
20 Nov 17
Cellectis Demonstrates Fine and Predictable Tuning of TALENĀ® Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy
12:00am
CORRESP
CLLS
Cellectis
14 Nov 17
Correspondence with SEC
12:00am
6-K
CLLS
Cellectis
13 Nov 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
13 Nov 17
Cellectis Reports Financial Results for Third Quarter and First Nine Months of 2017
12:00am
6-K
CLLS
Cellectis
7 Nov 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
3 Nov 17
Cellectis Announces Two Oral Presentations and One Poster Presentation at the 2017 ASH Annual Meeting
12:00am
6-K
CLLS
Cellectis
1 Nov 17
Cellectis S.a. 6-K
12:00am
UPLOAD
CLLS
Cellectis
31 Oct 17
Letter from SEC
12:00am
CORRESP
CLLS
Cellectis
10 Oct 17
Correspondence with SEC
12:00am
6-K
CLLS
Cellectis
4 Oct 17
Cellectis S.a. 6-K
12:00am
CORRESP
CLLS
Cellectis
25 Sep 17
Correspondence with SEC
12:00am
UPLOAD
CLLS
Cellectis
12 Sep 17
Letter from SEC
12:00am
6-K
CLLS
Cellectis
5 Sep 17
Cellectis Reports Clinical Hold of UCART123 Studies
12:00am
6-K
CLLS
Cellectis
1 Sep 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
17 Aug 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
2 Aug 17
Current report (foreign)
12:00am
6-K
CLLS
Cellectis
2 Aug 17
Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2017
12:00am
6-K
CLLS
Cellectis
25 Jul 17
Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering
12:00am
6-K
CLLS
Cellectis
25 Jul 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
24 Jul 17
Cellectis Granted Patent for CRISPR Use in T-Cells
12:00am